Beam Therapeutics Inc. (NASDAQ:BEAM), a biotechnology company at the forefront of precision genetic medicines with a market capitalization of $1.87 billion, is navigating a critical juncture in its ...

CRISPR Therapeutics AG (NASDAQ:CRSP), a leading biotechnology company specializing in gene-based medicines with a market capitalization of $3.45 billion, stands at a critical juncture as it navigates ...

Researchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends ...

The UK’s plans to adopt the latest gene editing technology face delays over fears they will clash with EU law if Downing ...

CRISPR-Cas9 pioneer presented with National Medal of Technology and Innovation in White House awards ceremony.

Bengaluru-based biotechnology startup, CrisprBits Private Limited, has inaugurated a CRISPR gene editing and diagnostics ...

Influential inventions often combine existing tools in new ways. The iPhone, for instance, amalgamated the telephone, web ...

UK ministers are pressing ahead with legislation to adopt gene editing technology despite warnings from Brussels that it ...

"It's been incredible to merge our disease models with this gene-editing technology," Minikel said. "Our lab is very fortunate to have the opportunity to work with Eric and Sonia, who have brought ...

The three-year partnership is another example of Vertex’s interest in improving on Casgevy, its CRISPR medicine for sickle ...